News

The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon." Exhaustion, tiredness, weariness... fatigue. We know...

As the number of cases of COVID-19 increases in the US and the world, people with rheumatic diseases are wondering if their immunosuppressants put them at greater risk of acquiring...

On March 19, the U.S. Food and Drug Administration (FDA) approved the testing of two drugs, chloroquine (hydroxychloroquine) and remdesivir, to treat people with COVID-19. The drugs have been given...

With all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...

You may have noticed that we added a new accessibility feature to our websites. This feature will allow community members to change the size, color, or contrast of the text...

The U.S. Food and Drug Administration (FDA) has approved Hyrimoz for the treatment of psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis (AS), Crohn’s disease in adults, ulcerative colitis, plaque...

Cimzia was recently approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis. Cimzia has been previously approved to treat other inflammatory conditions, including...

I called my rheumatologist the other day (yet again). My next infusion isn’t for another few weeks and I was in the middle of a serious flare. Swelling joints, aching...

Have a question about psoriatic arthritis and aren’t sure where to turn? The Q&A feature helps you get quick answers and suggestions from other community members. You can search through...

You may have noticed some changes around Psoriatic-Arthritis.com. We’re thrilled to announce that we’ve added some new features and functionality to provide an even better experience for the most important...